Eye test may reveal statin benefits for macular degeneration

NCT ID NCT04735263

First seen Jan 29, 2026 · Last updated May 13, 2026 · Updated 11 times

Summary

This study tests whether measuring how quickly your eyes adjust to the dark can serve as an early sign that high-dose atorvastatin is working for intermediate age-related macular degeneration (AMD). About 21 participants will take the statin and undergo regular dark adaptation tests and eye scans. The goal is to see if faster dark adaptation matches up with reduced drusen deposits, without directly aiming to cure or control the disease long-term.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Massachusetts Eye and Ear Infirmary

    RECRUITING

    Boston, Massachusetts, 02114, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.